NEW VACCINES AGAINST PANDEMIC A / H1N1 FLU VIRUS

摘要

The invention relates to vaccines against influenza virus, and in particular against influenza virus, which has the hemagglutinin gene, which contains the D222 mutation and which has the oseltamivir resistant neuramidinase gene. In some embodiments, the influenza virus vaccine further comprises a matrix protein containing a mutation that enhances a specific immune response in humans. The virus is suitable for the production of vaccines against hypervirulent and oseltamivir-resistant influenza.